APOL1 CKD Risk Alleles in New Mexico African American and American Indian Populations: Racial Disparity by Hu, Chien-An A. et al.
26 APOL1 CKD Risk Alleles in New Mexico African American and American Indian Populations: 
Racial Disparity 
Hu, Bierle, Shultz, and Shah 
 
Journal of Health Disparities Research and Practice Volume 12, MW-CTRIN Special Issue, 
Summer 2019 
 http://digitalscholarship.unlv.edu/jhdrp/    
Follow on Facebook:  Health.Disparities.Journal 
Follow on Twitter:  @jhdrp 
Journal of Health Disparities Research and Practice 
Volume 12, MW CTR-IN Special Issue, Summer 2019, pp. 26-29 
© 2011 Center for Health Disparities Research 
School of Public Health    
University of Nevada, Las Vegas 
 
APOL1 CKD Risk Alleles in New Mexico African American and 
American Indian Populations: Racial Disparity 
 
Chien-An A. Hu, Department of Biochemistry and Molecular Biology, University of New Mexico 
School of Medicine 
Amelia Bierle, Department of Biochemistry and Molecular Biology, University of New Mexico 
School of Medicine 
Matthew Shultz, Department of Biochemistry and Molecular Biology, University of New Mexico 
School of Medicine,  
Vallabh O. Shah, Department of Biochemistry and Molecular Biology, University of New Mexico 
School of Medicine 
Corresponding Author:  Chien-An A. Hu, AHu@salud.unm.edu 
 
ABSTRACT 
Purpose/Background: Two haplotypes of human apolipoprotein L1 gene (gene: APOL1; 
protein: ApoL1) harboring three coding sequence mutations have been demonstrated as risk 
variants associated with non-diabetic chronic kidney diseases (CKD) in African Americans. The 
first one, termed G1, is a two non-synonymous SNP haplotype (rs73885319 (A>G; p.S342G) and 
rs60910145 (G>T; p.I384M). The second one, termed G2, is a two codon deletion haplotype 
rs71785313 (6-bp in frame deletion) These two coding-sequence variants have been discovered in 
CKD patients of African ancestry and linked to the pathogenesis of primary focal and segmental 
glomerulosclerosis (FSGS), hypertension-attributed kidney disease, and HIV-associated 
nephropathy (HIVAN), under a recessive inheritance pattern. Marked disparities exist in races, 
rates, and etiological classifications of CDK between African Americans (AAs) and European 
Americans. Sequencing and genotyping analysis of known APOL1 SNPs showed that only APOL1 
G1 and G2 confer kidney risk, and other common and rare APOL1 missense variants, including 
the G3 haplotype, do not contribute to FSGS and HIVAN in the US population. 
According to the report of US census bureau, African American and American Indian (AI) 
citizens in New Mexico make up nearly 2.5% and 10.9% of the state's entire population in 2018 
(2). However, whether APOL1 G1 and G2 kidney-risk alleles are linked with hypertension-
attributed CKD in AAs and AIs in New Mexico has not been investigated. 
Materials & Methods:  We analyzed the published results of a retrospective analysis of 
inpatient and discharge data from hospitals across the state of New Mexico, known as Hospital 
Inpatient and Discharge Dataset (HIDD; 3). 
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Results:   A pattern persisted for all three years (2012-2014) that AAs had the highest rate 
of CKD followed by AIs per 10,000 population in New Mexico. AAs had the highest age adjusted 
rate of CKD with hypertension at 102.6 per 10,000 population (29.7% (102.6/345.7) of all CKD 
with hypertension patients) followed by American Indians at 91.9 (26.6% (91.9/345.7) of all CKD 
with hypertension patients). Interestingly, in terms of CKD with diabetes, AIs had the highest age 
adjusted rate at 79.9 per 10,000 followed by AAs at 66.5. 
Discussion/Conclusion:  The prevalence of CKD with hypertension in AA and AI 
populations is significantly high in New Mexico, To understand the etiology of CKD in AAs and 
AIs in New Mexico, genotyping the APOL1 G1 and G2 risk alleles in these two populations is 
warranted. Detection of APOL1 associations with CKD and delineation of injury pathways 
(autophagy, necroptosis and ferroptosis) would bring hope for effective treatment for these kidney 
diseases. In addition, modifier loci can influence APOL1 risk for the development of CKD. 
‘Second hits’, for example viral and environmental, may alter the outcome of APOL1 risk variants. 
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Table 1. Subject Chracteristics and Percentage of Chronic Absenteeism 
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Chronic 
Absenteeism 
 
Total 
Chronic 
Absenteeism 
Variable 
Unweighted N 
Weighted % 
(SE) 
Weighted % 
(SE) 
 Unweighted 
N 
Weighted % 
(SE) 
Weighted % 
(SE) 
Socio-Demographic Variable Family Structure Variable 
Age    Family Type    
6-13 yrs. 15,815 68.3 (0.4) 1.7 (0.1) Two-parent 22,524 69.4 (0.8) 1.8 (0.1) 
14-17 yrs. 6,696 31.7 (0.4) 3.1 (0.3) Single-parent 12,236 27.9 (0.8) 3.0 (0.2) 
Sex    No-parent 1,167 2.7 (0.2) 3.4 (0.8) 
Boy 11,524 51.0 (0.5) 2.1 (0.1) Family Size    
Girl 10,987 49.0 (0.5) 2.3 (0.2) ≤4 18,632 58.2 (0.9) 2.5 (0.2) 
Race/Ethnicity    >4 17,295 41.8 (0.9) 1.7 (0.2) 
White 7,342 56.4 (1.3) 2.6 (0.2) # of Elderly (≥65 yrs.)* 35,927 0.05 (0.00) 0.08 (0.01) 
Black 4,992 14.4 (0.8) 1.7 (0.3) 
# of Preschool Children 
(≤5 yrs.)* 
35,927 0.34 (0.01) 0.31 (0.03) 
Mexican 5,762 14.8 (1.2) 1.4 (0.1) # of Adult (≥18 yrs.)    
Other Hispanic 2,415 7.0 (0.4) 2.4 (0.3) 0-1 6,255 15.0 (0.5) 2.8 (0.3) 
Filipino 275 1.0 (0.2) 2.1 (1.1) 2 19,585 60.2 (0.7) 1.9 (0.1) 
Other Asians 979 3.4 (0.2) 0.5 (0.2) ≥3 10,087 24.8 (0.6) 2.5 (0.2) 
AI/AN/NHPI 330 1.3 (0.3) 3.5 (0.8) Health/Behavior Variable 
Other 416 1.8 (0.2) 2.1 (0.7) Asthma & Medication    
Highest Education in 
Family 
   
No Asthma 19,522 87.0 (0.3) 1.8 (0.1) 
≤High School 9,828 31.7 (0.9) 2.6 (0.2) 
Both Inhaler and 
Preventive Medicine 
1,496 6.5 (0.2) 4.1 (0.7) 
Some College 6,358 28.6 (0.6) 2.4 (0.2) Inhaler Only 125 0.7 (0.1) 1.5 (0.9) 
Bachelor’s 3,689 21.8 (0.7) 1.8 (0.3) 
Preventive Medicine 
Only 
931 4.0 (0.2) 5.2 (1.3) 
≥Graduate 2,622 17.9 (0.8) 1.5 (0.3) 
Neither Inhaler nor 
Preventive Medicine 
417 1.8 (0.1) 11.7 (2.2) 
Income    ADHD    
Poor 8,815 25.0 (0.8) 3.1 (0.2) Yes 2,194 10.7 (0.4) 2.0 (0.1) 
Low 4,195 15.6 (0.4) 2.4 (0.3) No 20,314 89.3 (0.4) 3.8 (0.4) 
Middle 5,833 32.0 (0.7) 2.2 (0.2) Obesity    
High 3,668 27.4 (0.9) 1.3 (0.2) Normal 13,771 83.1 (0.5) 2.2 (0.1) 
Insurance    Overweight 2,240 11.5 (0.4) 2.5 (0.3) 
Any Private 10,168 61.0 (1.0) 1.8 (0.1) Obese 1,197 5.4 (0.2) 4.8 (0.8) 
Public Only 10,666 32.4 (1.0) 3.1 (0.2) Behavioral Problem    
Uninsured 1,677 6.6 (0.4) 1.3 (0.4) CIS<15 19,636 86.4 (0.4) 1.6 (0.1) 
Born in US    CIS≥15 2,875 13.6 (0.4) 6.1 (0.5) 
No 6,522 17.3 (0.9) 0.8 (0.2) 
Number of Dental Care 
Visits* 
22,511 1.38 (0.03) 1.53 (0.19) 
Yes 15,981 82.7 (0.9) 2.3 (0.1) 
Less Healthy Than Other 
Child 
   
Language at Home    No 20,720 93.0 (0.2) 1.6 (0.1) 
Other 1,542 4.7 (0.2) 1.2 (0.1) Yes 1,776 7.0 (0.2) 10.1 (0.8) 
English 20,952 95.3 (0.2) 2.4 (0.1)  
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